Since there is no evidence supporting cardiovascular benefitsfrom DPP4 inhibitors and some of them might even raise the risk of heart failurehospitalizations, they may not be the best option for diabetic patients whoalready have heart failure or are at risk of developing it, such as olderpatients, obese patients, or those with a long history of DM [240]. Here, DPP4 is linked to heart failure.